Jul 17, 2024, 05:32
EA3202 for Advanced Head and Neck Cancer
ECOG-ACRIN Cancer Research Group shared a post on X:
“Clinical Trial EA3202, led by Aarti Bhatia of Yale Cancer Center, aims to improve results for patients with advanced-stage Head and Neck Cancer by comparing several treatment approaches. Learn more.” .
Source: ECOG-ACRIN/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 10:18
Nov 19, 2024, 10:05
Nov 19, 2024, 09:53
Nov 19, 2024, 09:44
Nov 19, 2024, 09:40
Nov 19, 2024, 09:28